Objective: To evaluate the efficacy and safety of iloprost, a prostacyclin analog, administered
intravenously in patients with Raynaud phenomenon secondary to systemic sclerosis. …

Objective. We conducted this study to assess the clinical usefulness and physiologic effects
of intravenous iloprost in patients with Raynaud's phenomenon secondary to sys-temic …

Objective. Raynaud’s phenomenon (RP) is an important clinical feature of systemic sclerosis
(SSc) for which consistently effective therapies are lacking. The study was designed to …

ATCC 6650) have led tothe isolation of brassicicolin A (6), a novel isocyanide antibiotic with
potent in vitro activity against the gram-positive bacteria Bacillus subtilis and …

Objective To investigate the safety and pharmacokinetics of a 28 day continuous subcutaneous
infusion of recombinant human relaxin in patients with systemic sclerosis with diffuse …

Argininosuccinic acid lyase (ASAL) deficiency is a clinically heterogeneous autosomal
recessive urea cycle disorder. We previously established by complementation analysis that 28 …

OBJECTIVE:. To assess the efficacy and tolerability of bosentan in pulmonary arterial
hypertension secondary to systemic sclerosis (SSc-PAH) including patients with restrictive lung …

Advances in our understanding of the pathobiology of scleroderma and the ever-increasing
availability of rational candidate therapies have brought the clinical study of scleroderma to …

Background Protection from severe disease and hospitalization by SARS-CoV-2 vaccination
has been amply demonstrated by real-world data. However, the rapidly evolving pandemic …

… The entire book is molded around Deborah McCloskey's heartfeltdesire for her clients to
be free of drugs. Her counseling methods both endearedher as" the counselor to get" and …